Ih-Jen Su Selected Research

T-Cell Lymphoma (Lymphoma, T Cell)

3/2012	Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
4/2010	BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan.
9/2007	Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
5/2007	Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
1/2004	Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ih-Jen Su Research Topics

Disease

35	Infections 01/2019 - 11/2003
29	Neoplasms (Cancer) 01/2020 - 03/2003
25	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2004
12	Carcinogenesis 01/2021 - 02/2002
11	Chronic Hepatitis B 01/2021 - 12/2003
9	Nasopharyngeal Carcinoma 06/2012 - 06/2002
8	Human Influenza (Influenza) 11/2019 - 08/2006
8	Lymphoma (Lymphomas) 02/2015 - 06/2002
7	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2008 - 01/2003
5	Hepatitis B 01/2019 - 12/2004
5	Genomic Instability 07/2015 - 10/2004
5	Encephalitis (Encephalitis, Rasmussen) 07/2013 - 08/2003
5	T-Cell Lymphoma (Lymphoma, T Cell) 03/2012 - 01/2004
4	Disease Progression 01/2016 - 09/2005
4	Neoplasm Metastasis (Metastasis) 09/2014 - 04/2007
3	Tuberculosis (Tuberculoses) 02/2017 - 05/2006
3	Hodgkin Disease (Hodgkin's Disease) 01/2017 - 03/2003
3	Retinoblastoma (Glioblastoma, Retinal) 02/2013 - 10/2007
3	Severe Acute Respiratory Syndrome 02/2010 - 02/2005
3	Virus Diseases (Viral Diseases) 01/2010 - 11/2004
3	Fever (Fevers) 02/2005 - 07/2004
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2020
2	Inflammation (Inflammations) 07/2020 - 09/2014
2	Epstein-Barr Virus Infections 01/2017 - 11/2005
2	Chromosomal Instability (Chromosome Stability) 04/2016 - 02/2012
2	Pulmonary Edema 07/2013 - 08/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2012 - 01/2010
2	Hyperglycemia 01/2012 - 05/2008
2	Cross Infection (Nosocomial Infection) 07/2009 - 03/2005
2	Hepatitis 03/2008 - 06/2003
2	Cytokine Release Syndrome 09/2007 - 02/2005
2	Liver Diseases (Liver Disease) 10/2005 - 09/2005
1	Colonic Neoplasms (Colon Cancer) 11/2018
1	Paramyxoviridae Infections (Parainfluenza) 09/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2015
1	Nijmegen Breakage Syndrome 07/2015

Drug/Important Bio-Agent (IBA)

14	Surface Antigens (Surface Antigen)IBA 01/2018 - 12/2003
11	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 10/2007
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
9	VaccinesIBA 11/2019 - 12/2004
9	CytokinesIBA 01/2017 - 08/2003
6	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 11/2004
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 06/2003
5	ChemokinesIBA 05/2013 - 02/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 02/2002
5	AntibodiesIBA 03/2011 - 03/2003
4	CurcuminIBA 01/2022 - 11/2018
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2011
4	Biological ProductsIBA 07/2020 - 03/2005
4	Antiviral Agents (Antivirals)IBA 01/2018 - 05/2013
4	TOR Serine-Threonine KinasesIBA 01/2017 - 10/2011
3	LipidsIBA 01/2019 - 02/2012
3	CarbohydratesIBA 01/2018 - 03/2011
3	Amiodarone (Amiodarona)FDA LinkGeneric 01/2018 - 02/2014
3	Polysaccharides (Glycans)IBA 01/2018 - 03/2011
3	Complementary DNA (cDNA)IBA 01/2016 - 02/2002
3	SteroidsIBA 09/2015 - 06/2003
3	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 11/2003
3	Dexamethasone (Maxidex)FDA LinkGeneric 02/2015 - 12/2005
3	AntigensIBA 01/2015 - 03/2003
3	Carrier Proteins (Binding Protein)IBA 01/2015 - 08/2008
3	Cyclin AIBA 02/2012 - 08/2008
3	Neutralizing AntibodiesIBA 01/2012 - 11/2005
2	Interleukin-13IBA 01/2017 - 11/2011
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 02/2012
2	CholesterolIBA 01/2016 - 02/2012
2	Mutant Proteins (Protein, Mutant)IBA 10/2014 - 11/2004
2	Viral ProteinsIBA 09/2014 - 07/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014 - 06/2009
2	Mitogen-Activated Protein Kinase 3IBA 06/2014 - 07/2013
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2013 - 06/2012
2	Interferon-gamma (Interferon, gamma)IBA 05/2013 - 02/2005
2	Hemagglutinins (Hemagglutinin)IBA 04/2012 - 03/2011
2	Therapeutic UsesIBA 01/2012 - 03/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2009 - 09/2005
2	Interleukin-8 (Interleukin 8)IBA 10/2008 - 04/2008
2	RNA (Ribonucleic Acid)IBA 07/2008 - 07/2005
2	Messenger RNA (mRNA)IBA 11/2004 - 02/2002
1	Amyloid (Amyloid Fibrils)IBA 07/2020
1	B7-H1 AntigenIBA 01/2020
1	NucleotidesIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Cyclin D1IBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2018
1	CalciumIBA 04/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	lipoarabinomannan (LAM)IBA 01/2016
1	Karyopherins (Importin)IBA 07/2015
1	Etoposide (VP 16)FDA LinkGeneric 02/2015
1	Mesna (Coenzyme M)FDA LinkGeneric 02/2015
1	Cisplatin (Platino)FDA LinkGeneric 02/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2015

Therapy/Procedure

12	Therapeutics 01/2021 - 09/2005
8	Drug Therapy (Chemotherapy) 07/2014 - 06/2003
3	Chemoprevention 01/2019 - 02/2013
3	Radiotherapy 07/2014 - 01/2004
2	Hepatectomy 01/2018 - 07/2011
1	Chemoradiotherapy 02/2015
1	Consolidation Chemotherapy 02/2015